# Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

Study · id `cardio:ct-nct05473520` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05473520](<https://clinicaltrials.gov/study/NCT05473520>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05473520

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT05473520. Randomized; quadruple masking; primary purpose treatment. Start 2023-05-24 (actual); primary completion 2030-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT05473520, source copy `cardio:ctgov-nct05473520-2026-06-09`, retrieved 2026-10-31)
- Started: 2023-05-24 (actual) (ClinicalTrials.gov record NCT05473520, source copy `cardio:ctgov-nct05473520-2026-06-09`, retrieved 2026-10-31)
- Primary completion: 2030-01-31 (anticipated) (ClinicalTrials.gov record NCT05473520, source copy `cardio:ctgov-nct05473520-2026-06-09`, retrieved 2026-10-31)
- Completion: 2030-01-31 (anticipated) (ClinicalTrials.gov record NCT05473520, source copy `cardio:ctgov-nct05473520-2026-06-09`, retrieved 2026-10-31)
- Countries: Malaysia; Singapore (ClinicalTrials.gov record NCT05473520, source copy `cardio:ctgov-nct05473520-2026-06-09`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05473520-2026-06-09`, retrieved 2026-10-31)

## The registry's words

- Brief title: Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
- Acronym: Doxy-TB
- Condition: Tuberculosis
- Condition: Acute Coronary Syndrome
- Condition: Pulmonary Hypertension (Diagnosis)
- Intervention (Drug): Doxycycline
- Intervention (Drug): Placebo
- Lead sponsor: National University Hospital, Singapore
- Lead sponsor class: OTHER
- Collaborator: Tan Tock Seng Hospital
- Collaborator class: OTHER
- Collaborator: Hospital Queen Elizabeth, Malaysia
- Collaborator class: OTHER\_GOV
- Collaborator: National University of Singapore
- Collaborator class: OTHER
- Collaborator: University Malaysia Sabah
- Collaborator class: UNKNOWN
- Collaborator: Menggatal Health Clinic, Sabah, Malaysia
- Collaborator class: UNKNOWN
- Collaborator: Luyang Health Clinic, Sabah, Malaysia
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)
- Registry lists this organization as the lead sponsor: National University Hospital, Singapore (`cardio:org-national-university-hospital-singapore`)
- Registry lists this organization as a collaborator: Tan Tock Seng Hospital (`cardio:org-tan-tock-seng-hospital`)
- Registry lists this organization as a collaborator: National University of Singapore (`cardio:org-national-university-of-singapore`)

## Provenance

Content hash: f1c1f0f8ddbf08b544f47ae11fd230046bf7f7d57b89b5f1d7e6a0a2b936a135
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
